Copyright Reports & Markets. All rights reserved.

Global Sheep and Goat Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sheep and Goat Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Live Attenuated Vaccines
    • 1.3.3 Inactivated Vaccines
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sheep and Goat Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Sheep
    • 1.4.3 Goat
  • 1.5 Global Sheep and Goat Vaccines Market Size & Forecast
    • 1.5.1 Global Sheep and Goat Vaccines Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Sheep and Goat Vaccines Sales Quantity (2021-2032)
    • 1.5.3 Global Sheep and Goat Vaccines Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Sheep and Goat Vaccines Product and Services
    • 2.1.4 Merck Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Zoetis
    • 2.2.1 Zoetis Details
    • 2.2.2 Zoetis Major Business
    • 2.2.3 Zoetis Sheep and Goat Vaccines Product and Services
    • 2.2.4 Zoetis Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zoetis Recent Developments/Updates
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Sheep and Goat Vaccines Product and Services
    • 2.3.4 Boehringer Ingelheim Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.4 Ceva
    • 2.4.1 Ceva Details
    • 2.4.2 Ceva Major Business
    • 2.4.3 Ceva Sheep and Goat Vaccines Product and Services
    • 2.4.4 Ceva Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ceva Recent Developments/Updates
  • 2.5 CAHIC
    • 2.5.1 CAHIC Details
    • 2.5.2 CAHIC Major Business
    • 2.5.3 CAHIC Sheep and Goat Vaccines Product and Services
    • 2.5.4 CAHIC Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CAHIC Recent Developments/Updates
  • 2.6 HVRI
    • 2.6.1 HVRI Details
    • 2.6.2 HVRI Major Business
    • 2.6.3 HVRI Sheep and Goat Vaccines Product and Services
    • 2.6.4 HVRI Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 HVRI Recent Developments/Updates
  • 2.7 Ringpu Biology
    • 2.7.1 Ringpu Biology Details
    • 2.7.2 Ringpu Biology Major Business
    • 2.7.3 Ringpu Biology Sheep and Goat Vaccines Product and Services
    • 2.7.4 Ringpu Biology Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ringpu Biology Recent Developments/Updates
  • 2.8 Yebio
    • 2.8.1 Yebio Details
    • 2.8.2 Yebio Major Business
    • 2.8.3 Yebio Sheep and Goat Vaccines Product and Services
    • 2.8.4 Yebio Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Yebio Recent Developments/Updates
  • 2.9 DHN
    • 2.9.1 DHN Details
    • 2.9.2 DHN Major Business
    • 2.9.3 DHN Sheep and Goat Vaccines Product and Services
    • 2.9.4 DHN Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 DHN Recent Developments/Updates
  • 2.10 WINSUN
    • 2.10.1 WINSUN Details
    • 2.10.2 WINSUN Major Business
    • 2.10.3 WINSUN Sheep and Goat Vaccines Product and Services
    • 2.10.4 WINSUN Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 WINSUN Recent Developments/Updates
  • 2.11 Elanco
    • 2.11.1 Elanco Details
    • 2.11.2 Elanco Major Business
    • 2.11.3 Elanco Sheep and Goat Vaccines Product and Services
    • 2.11.4 Elanco Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Elanco Recent Developments/Updates
  • 2.12 Virbac
    • 2.12.1 Virbac Details
    • 2.12.2 Virbac Major Business
    • 2.12.3 Virbac Sheep and Goat Vaccines Product and Services
    • 2.12.4 Virbac Sheep and Goat Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Virbac Recent Developments/Updates

3 Competitive Environment: Sheep and Goat Vaccines by Manufacturer

  • 3.1 Global Sheep and Goat Vaccines Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Sheep and Goat Vaccines Revenue by Manufacturer (2021-2026)
  • 3.3 Global Sheep and Goat Vaccines Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Sheep and Goat Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Sheep and Goat Vaccines Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Sheep and Goat Vaccines Manufacturer Market Share in 2025
  • 3.5 Sheep and Goat Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Sheep and Goat Vaccines Market: Region Footprint
    • 3.5.2 Sheep and Goat Vaccines Market: Company Product Type Footprint
    • 3.5.3 Sheep and Goat Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sheep and Goat Vaccines Market Size by Region
    • 4.1.1 Global Sheep and Goat Vaccines Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Sheep and Goat Vaccines Consumption Value by Region (2021-2032)
    • 4.1.3 Global Sheep and Goat Vaccines Average Price by Region (2021-2032)
  • 4.2 North America Sheep and Goat Vaccines Consumption Value (2021-2032)
  • 4.3 Europe Sheep and Goat Vaccines Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Sheep and Goat Vaccines Consumption Value (2021-2032)
  • 4.5 South America Sheep and Goat Vaccines Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Sheep and Goat Vaccines Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 5.2 Global Sheep and Goat Vaccines Consumption Value by Type (2021-2032)
  • 5.3 Global Sheep and Goat Vaccines Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 6.2 Global Sheep and Goat Vaccines Consumption Value by Application (2021-2032)
  • 6.3 Global Sheep and Goat Vaccines Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 7.2 North America Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 7.3 North America Sheep and Goat Vaccines Market Size by Country
    • 7.3.1 North America Sheep and Goat Vaccines Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Sheep and Goat Vaccines Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 8.2 Europe Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 8.3 Europe Sheep and Goat Vaccines Market Size by Country
    • 8.3.1 Europe Sheep and Goat Vaccines Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Sheep and Goat Vaccines Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Sheep and Goat Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Sheep and Goat Vaccines Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Sheep and Goat Vaccines Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 10.2 South America Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 10.3 South America Sheep and Goat Vaccines Market Size by Country
    • 10.3.1 South America Sheep and Goat Vaccines Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Sheep and Goat Vaccines Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Sheep and Goat Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Sheep and Goat Vaccines Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Sheep and Goat Vaccines Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Sheep and Goat Vaccines Market Drivers
  • 12.2 Sheep and Goat Vaccines Market Restraints
  • 12.3 Sheep and Goat Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sheep and Goat Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sheep and Goat Vaccines
  • 13.3 Sheep and Goat Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sheep and Goat Vaccines Typical Distributors
  • 14.3 Sheep and Goat Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sheep and Goat Vaccines market size was valued at US$ 1256 million in 2025 and is forecast to a readjusted size of US$ 1948 million by 2032 with a CAGR of 6.5% during review period.
    Sheep and goat vaccines are vaccines that are specifically designed for use in sheep and goats to prevent various diseases that can affect these animals. Some of the commonly used sheep and goat vaccines include those for diseases such as Clostridial diseases like Tetanus and Pulpy Kidney, Foot Rot, Pasteurella, and Contagious Ecthyma (Orf). These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of sheep and goat herds.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Sheep and Goat Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sheep and Goat Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sheep and Goat Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sheep and Goat Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Sheep and Goat Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sheep and Goat Vaccines
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sheep and Goat Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sheep and Goat Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Live Attenuated Vaccines
    Inactivated Vaccines
    Other
    Market segment by Application
    Sheep
    Goat
    Major players covered
    Merck
    Zoetis
    Boehringer Ingelheim
    Ceva
    CAHIC
    HVRI
    Ringpu Biology
    Yebio
    DHN
    WINSUN
    Elanco
    Virbac
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sheep and Goat Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sheep and Goat Vaccines, with price, sales quantity, revenue, and global market share of Sheep and Goat Vaccines from 2021 to 2026.
    Chapter 3, the Sheep and Goat Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sheep and Goat Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sheep and Goat Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sheep and Goat Vaccines.
    Chapter 14 and 15, to describe Sheep and Goat Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now